M. G. Cabral

This paper validates HLA-DR expression in cytotoxic T lymphocytes as a predictive biomarker for breast cancer response to neoadjuvant chemotherapy and shows its association with progression-free survival.

This study shows that low density neutrophils (LDN) in breast cancer patients are linked to worse prognosis due to their immunosuppressive effects on T cell responses.

This study identifies ancestry-associated gene and protein expression differences in Triple-Negative Breast Cancer between African-ancestry and White patients, highlighting EGFR, Myc, Bcl2, and β-Catenin as potential markers.